Forward Equity Partners
Overview
Forward Equity Partners is a private equity firm based in Seoul, South Korea that focuses on cross-border investments in the healthcare, life science, and biotechnology sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Artiva Biotherapeutics | Jun 2020 | Series A | Co-investor |
| SoVarGen Co., Ltd. | Dec 2020 | Series B | Co-investor |
| UBIX BIO INC. | Mar 2023 | Series C | Co-investor |
| SCAI Therapeutics | Jul 2021 | Series B | Co-investor |
| WindMIL Therapeutics | Jun 2018 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Forward Equity Partners based?
Forward Equity Partners is headquartered in Seoul, South Korea.
When was Forward Equity Partners founded?
Forward Equity Partners was founded in 2021.
How many portfolio companies does Forward Equity Partners have?
Forward Equity Partners has 6 portfolio companies in Caplight's dataset.
What are some companies in Forward Equity Partners's portfolio?
Portfolio companies visible on Caplight include Artiva Biotherapeutics, SoVarGen Co., Ltd., UBIX BIO INC., SCAI Therapeutics, WindMIL Therapeutics.
What was Forward Equity Partners's most recent investment shown here?
Forward Equity Partners's most recent investment in this portfolio sample was in UBIX BIO INC. in 2023.
What sectors does Forward Equity Partners focus on?
Forward Equity Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Forward Equity Partners focus on?
Forward Equity Partners typically invests at the Mid stage.